Patents by Inventor Thomas M. Connolly

Thomas M. Connolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6838291
    Abstract: The present invention is directed to the radioligand compound, [35S]-radiolabeled (+)-N-[1?-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-hydoxyspiro[2H-1-benzopyran-2,4?-piperidin]-6-yl]methanesulfonamide. Also within the scope of this invention is a method for identifying compounds that bind to the IKr channel, and may have antiarrhythmic activity.
    Type: Grant
    Filed: July 12, 2001
    Date of Patent: January 4, 2005
    Assignee: Merck & Co., Inc.
    Inventors: John W. Butcher, David A. Claremon, Thomas M. Connolly, Jerzy Karczewski, Kenneth S. Koblan, Matthew J. Kostura, Nigel J. Liverton, Dennis C. Dean, David G. Melillo
  • Publication number: 20030212262
    Abstract: The present invention provides polynucleotides and polypeptides of a human serine racemase. The polynucleotides and polypeptides are used to further provide expression vectors, host cells comprising the vectors, probes and primers, antibodies against the serine racemase protein and polypeptides thereof, assays for the presence or expression of serine racemase and assays for the identification of compounds that interact with serine racemase and transgenic animals expressing human serine racemase.
    Type: Application
    Filed: October 3, 2002
    Publication date: November 13, 2003
    Inventors: Thomas M Connolly, Yuan Liu, Menghang Xia
  • Patent number: 6515023
    Abstract: A thrombin receptor antagonist having the formula useful for inhibiting the aggregation of blood platelets. The compounds can be used in a method of acting upon a thrombin receptor which comprises administering a therapeutically effective but non-toxic amount of such compound to a mammal, preferably a human.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: February 4, 2003
    Assignee: Merck & Co., Inc.
    Inventors: James C. Barrow, Philippe G. Nantermet, Harold G. Selnick, John H. Hutchinson, Michael J. Breslin, Kristen L. Glass, Thomas M. Connolly, Andrew Stern
  • Publication number: 20020034730
    Abstract: The present invention is directed to the radioligand compound, [35S]-radiolabeled (+)-N-[1′-(6-cyano-1,2,3,4-tetrahydro-2(R)-naphthalenyl)-3,4-dihydro-4(R)-hydoxyspiro[2H-1-benzopyran-2,4′-piperidin]-6-yl]methanesulfonamide. Also within the scope of this invention is a method for identifying compounds that bind to the IKr channel, and may have antiarrhythmic activity.
    Type: Application
    Filed: July 12, 2001
    Publication date: March 21, 2002
    Inventors: John W. Butcher, David A. Claremon, Thomas M. Connolly, Jerzy Karczewski, Kenneth S. Koblan, Matthew J. Kostura, Nigel J. Liverton, Dennis C. Dean, David G. Melillo
  • Publication number: 20020007045
    Abstract: A thrombin receptor antagonist having the formula 1
    Type: Application
    Filed: January 30, 2001
    Publication date: January 17, 2002
    Inventors: James C. Barrow, Philippe G. Nantermet, Harold G. Selnick, John H. Hutchinson, Michael J. Breslin, Kristen L. Glass, Thomas M. Connolly, Andrew Stern
  • Patent number: 5681926
    Abstract: Peptides having the general sequence A-B-C-D-E-F-Z wherein A is Ala, B is pFPhe, C is, for example, Arg, D is Cha, E is, for example, hArg, F is, for example, Tyr, and Z is, for example NH.sub.2. The peptides are useful for promoting wound healing and arresting bleeding in a patient.
    Type: Grant
    Filed: December 15, 1995
    Date of Patent: October 28, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Daniel F. Veber, Ruth F. Nutt, Dong-Mei Feng, Robert J. Gould, Thomas M. Connolly
  • Patent number: 5613676
    Abstract: A sporting net which can be utilized either as a hockey net or a basketball hoop. The apparatus includes a center post having a basketball hoop and its upper end. Furthermore, two linkages are pivotally secured at opposing locations at the intermediate extent of the center post. A hockey net is secured in between these two linkages. In order to facilitate storage of the sporting net, the linkages are pivotal between a first use orientation, wherein they extend laterally from the post then downwardly to abut a recipient surface and a second storage orientation wherein they are positioned generally next to the post.
    Type: Grant
    Filed: April 1, 1996
    Date of Patent: March 25, 1997
    Inventor: Thomas M. Connolly
  • Patent number: 5457177
    Abstract: The radioligands are six amino acid peptides having iodinated tyrosine at amino acid position six, including Ala-pFPhe-hArg-Cha-hArg-Tyr(I)-NH.sub.2, which mimic the activated form of the thrombin receptor protein. Thrombin receptor radioligands of the present invention are useful for screening for thrombin receptor antagonists.
    Type: Grant
    Filed: June 16, 1993
    Date of Patent: October 10, 1995
    Assignee: Merck & Co., Inc.
    Inventors: Daniel F. Veber, Ruth F. Nutt, Dong-mei Feng, Robert J. Gould, Thomas M. Connolly
  • Patent number: 5340726
    Abstract: A protein which inhibits collagen-stimulated platelet aggregation. The protein has a molecular weight of approximately 17,000. A method of isolating the protein from Ornithodoros moubata and using the protein to prevent or delay blood coagulation by blocking the stimulation of platelet aggregation by collagen is also described. The protein is useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: August 23, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Thomas M. Connolly, Paul M. Keller, Lloyd H. Waxman
  • Patent number: 5324715
    Abstract: A protein isolated from crude Haementeria officinalis extract which blocks stimulation of platelet aggregation by collagen. The protein has a molecular weight of approximately 16,000. A method of isolating the protein and using the protein to prevent or delay blood coagulation by blocking the stimulation of platelet aggregation by collagen is also described. The protein is useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.
    Type: Grant
    Filed: April 7, 1993
    Date of Patent: June 28, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Thomas M. Connolly, Paul M. Keller
  • Patent number: 5321010
    Abstract: The invention comprises proteinaceous substances isolated from crude Ornithodoros moubata extract which inhibit adhesion of platelets to collagen. These substances do not inhibit platelet adhesion to fibrinogen, and are therefore particularly useful for inhibiting adhesion of platelets to collagen when simultaneous inhibition of platelet adhesion to fibrinogen is undesired. They are particularly useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.
    Type: Grant
    Filed: December 10, 1991
    Date of Patent: June 14, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Thomas M. Connolly, Michael Neeper, Lloyd Waxman
  • Patent number: 5179082
    Abstract: A method for blocking platelet adhesion to collagen by contacting platelets with a polypeptide having one of the following sequences:NH.sub.2 (Ch) Ala Arg Gly Asp (Cx) COOH (i)NH.sub.2 (Ch) Ala Ala Gly Asp (Cx) COOH (ii)NH.sub.2 (Ch) Ala Arg Tyr Asp (CX) COOH (iii)NH.sub.2 (Ch) Ala Arg Gly Asp (Cy) Z (iv)wherein Ch, Cx, Cy are defined amino acid sequences or conservatively substituted amino acid sequences, and Z is NH.sub.2 or COOH.
    Type: Grant
    Filed: February 27, 1991
    Date of Patent: January 12, 1993
    Assignee: Merck & Co., Inc.
    Inventors: Thomas M. Connolly, Jerzy Karczewski
  • Patent number: 4038660
    Abstract: Microwave absorbers reduce radar cross-sections of airborne objects by attenuating reflectivity values. In Jaumann absorbers laminated layers are placed on the reflecting surfaces, the laminated layers being lossy layers separated by dielectric spacing layers. From the point of view of accuracy and reproducibility Jaumann absorbers have been difficult to construct. A mode of fabrication overcoming these difficulties is provided herein.
    Type: Grant
    Filed: August 5, 1975
    Date of Patent: July 26, 1977
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas M. Connolly, Eino J. Luoma
  • Patent number: 4027384
    Abstract: Microwave absorbers reduce radar cross-sections of airborne objects by attenuating reflectivity values. In Jaumann absorbers laminated layers are placed on the reflecting surfaces, the laminated layers being lossy layers separated by dielectric spacing layers. From the point of view of accuracy and reproducibility Jaumann absorbers have been difficult to construct. A mode of fabrication overcoming these difficulties is provided herein.
    Type: Grant
    Filed: November 19, 1976
    Date of Patent: June 7, 1977
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Thomas M. Connolly, Eino J. Luoma